AVROBIO Inc. (AVRO) Prices 5M Share Common Offering at $15/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
- AppLovin gains market share among e-commerce advertisers
After-Hours Stock Movers 11/19: (MESO) (FEYE) (NGVC) Higher; (AVRO) (WDAY) (SFIX) Lower (more...)
November 19, 2020 5:43 PM ESTToday's After-Hours Stock Movers:
Mesoblast Limited (Nasdaq: MESO) 27.7% HIGHER; announced that it has entered into an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of Mesoblasts mesenchymal stromal cell (MSC) product remestemcel-L, with an initial focus on the development of the treatment of acute respiratory distress syndrome (ARDS), including that associated with COVID-19.
FireEye, Inc. (NASDAQ: FEYE) 19.1% HIGHER; announced a $400 million strategic investment led by Blackstone Tactical Opportunities to... More
AVROBIO Inc. (AVRO) Announces $75M Proposed Public Offering of Common Stock
November 19, 2020 4:10 PM ESTAVROBIO, Inc. (NASDAQ: AVRO), a leading clinical-stage gene therapy company, today announced that it intends to offer and sell, subject to market and other conditions, $75 million of its common stock in an underwritten public offering.
The company expects to grant the underwriters a 30-day option to purchase up to $11.25 million of additional shares of its common stock (15 percent) offered in the public offering. All of the shares in the proposed offering are to be sold by the company. The offering is... More
